Skip to main content

Table 4 Multivariate analysis of platelet reactivity in patients under ticagrelor

From: Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study

  Coefficient (SE) t 95 % CI Exponentiated coefficient* p-value
Male gender 0.04 (0.11) 0.15 −0.17 to 0.26 1.04 0.7
Current smoking −0.19 (0.15) 1.54 −0.48 to 0.11 0.83 0.2
-Insulin-treated diabetes mellitus (vs non-diabetic status) 0.10 (0.18) 0.28 −0.26 to 0.45 1.11 0.6
-Non insulin-treated diabetes mellitus (vs non-diabetic status) 0.08 (0.10) 0.74 −0.11 to 0.27 1.08 0.4
Age 0.001 (0.005) 0.04 −0.008 to 0.01 1.001 0.9
Body mass index −0.002 (0.01) 0.03 −0.02 to 0.02 0.998 0.9
Creatinine clearance < 60 ml/min 0.20 (0.12) 2.98 −0.03 to 0.43 1.22 0.08
Statin 0.33 (0.19) 2.99 −0.04 to 0.71 1.39 0.08
Proton pump inhibitor 0.07 (0.17) 0.18 −0.26 to 0.41 1.07 0.7
Hypertension 0.006 (0.09) 0.005 −0.17 to 0.18 1.006 0.9
STEMI at admission −0.12 (0.09) 1.80 −0.29 to 0.05 0.89 0.2
  1. Abbreviations as in Table 2